Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62016TA0049

    Case T-49/16: Judgment of the General Court of 6 April 2017 — Azanta v EUIPO — Novartis (NIMORAL) (EU trade mark — Opposition proceedings — Application for the EU word mark NIMORAL — Earlier EU word mark NEORAL — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009)

    OJ C 161, 22.5.2017, p. 26–26 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    22.5.2017   

    EN

    Official Journal of the European Union

    C 161/26


    Judgment of the General Court of 6 April 2017 — Azanta v EUIPO — Novartis (NIMORAL)

    (Case T-49/16) (1)

    ((EU trade mark - Opposition proceedings - Application for the EU word mark NIMORAL - Earlier EU word mark NEORAL - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EC) No 207/2009))

    (2017/C 161/36)

    Language of the case: English

    Parties

    Applicant: Azanta A/S (Hellerup, Denmark) (represented by: M. Hoffgaard Rasmussen, lawyer)

    Defendant: European Union Intellectual Property Office (represented by: J. Ivanauskas, Agent)

    Other parties to the proceedings before the Board of Appeal of EUIPO: Novartis AG (Basel, Switzerland)

    Re:

    Action brought against the decision of the Fourth Board of Appeal of EUIPO of 1 December 2015 (Case R 634/2015-4), relating to opposition proceedings between Novartis and Azanta.

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Azanta A/S to pay the costs.


    (1)  OJ C 106, 21.3.2016.


    Top